Pacira BioSciences Inc

NASDAQ:PCRX   3:59:51 PM EDT
53.20
-0.64 (-1.19%)
Earnings Announcements

Pacira Biosciences Reports Preliminary Net Product Sales Of $36.2 Mln For Feb. 2021

Published: 03/09/2021 13:38 GMT
Pacira BioSciences Inc (PCRX) - Pacira Biosciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021.
Pacira Biosciences Inc - Exparel Average Daily Sales at 103% of Prior Year for Month of February 2021.
Pacira Biosciences - Preliminary Unaudited Net Product Sales of Exparel and Iovera of $35.6 Million and $0.7 Million, Respectively, for Feb 2021.
Revenue is expected to be $138.07 Million
Adjusted EPS is expected to be $0.76

Next Quarter Revenue Guidance is expected to be $146.25 Million
Next Quarter EPS Guidance is expected to be $0.86

More details on our Analysts Page.